Prostate cancer drugs charities have expressed anger and frustration at the NHS’s refusal to provide life-saving prostate cancer drug abiraterone in England. The drug has been available for two years in Scotland and Wales for high-risk patients whose cancer has not yet spread. But thousands of patients in England and Northern Ireland are being denied access to it. In a letter to Prostate Cancer UK, Health Minister Karin Smith said the decision by NHS England was made “based on overall financial capacity” after a lengthy review and “should not be…
Read MoreProstate cancer drugs: Life-saving drugs unavailable in England
